Skip to main content
    • Aa
    • Aa
  • Get access
    Check if you have access via personal or institutional login
  • Cited by 7
  • Cited by
    This article has been cited by the following publications. This list is generated based on data provided by CrossRef.

    Davis, T. Keefe McKee, Ryan Schnadower, David and Tarr, Phillip I. 2013. Treatment of Shiga Toxin–Producing Escherichia coli Infections. Infectious Disease Clinics of North America, Vol. 27, Issue. 3, p. 577.

    Pollock, Kevin G.J. 2013. HUS Surveillance Notes—Sarah’s Story. Emerging Infectious Diseases, Vol. 19, Issue. 3,

    Chen, M.-H. Chen, M.-H. Chen, W.-S. Mu-Hsin Chang, P. Lee, H.-T. Lin, H.-Y. and Huang, D.-F. 2011. Thrombotic microangiopathy in systemic lupus erythematosus: a cohort study in North Taiwan. Rheumatology, Vol. 50, Issue. 4, p. 768.

    Douglas, Kenneth W. Pollock, Kevin G.J. Young, David Catlow, Jamie and Green, Rachel 2010. Infection frequently triggers thrombotic microangiopathy in patients with preexisting risk factors: A single-institution experience. Journal of Clinical Apheresis, p. NA.

    Pollock, Kevin G.J. Locking, Mary E. Beattie, T. James Maxwell, Heather Ramage, Ian Hughes, David Cowieson, Jennifer Allison, Lesley Hanson, Mary and Cowden, John M. 2010. Sorbitol-fermentingEscherichia coliO157, Scotland. Emerging Infectious Diseases, Vol. 16, Issue. 5, p. 881.

    Tarr, Phillip I 2009. Shiga toxin-associated hemolytic uremic syndrome and thrombotic thrombocytopenic purpura: distinct mechanisms of pathogenesis. Kidney International, Vol. 75, p. S29.

    Schimmer, Barbara Nygard, Karin Eriksen, Hanne-Merete Lassen, Jørgen Lindstedt, Bjørn-Arne Brandal, Lin T Kapperud, Georg and Aavitsland, Preben 2008. Outbreak of haemolytic uraemic syndrome in Norway caused by stx 2-positive Escherichia coliO103:H25 traced to cured mutton sausages. BMC Infectious Diseases, Vol. 8, Issue. 1,


Clinical surveillance of thrombotic microangiopathies in Scotland, 2003–2005

  • K. G. J. POLLOCK (a1), D. YOUNG (a1), T. J. BEATTIE (a2) and W. T. A. TODD (a3)
  • DOI:
  • Published online: 05 March 2007

The prevalence, incidence and outcomes of haemolytic uraemic syndrome (HUS) and thrombotic thrombocytopaenic purpura (TTP) are not well established in adults or children from prospective studies. We sought to identify both outcomes and current management strategies using prospective, national surveillance of HUS and TTP, from 2003 to 2005 inclusive. We also investigated the links between these disorders and factors implicated in the aetiology of HUS and TTP including infections, chemotherapy, and immunosuppression. Most cases of HUS were caused by verocytotoxin-producing Escherichia coli (VTEC), of which serotype O157 predominated, although other serotypes were identified. The list of predisposing factors for TTP was more varied although use of immunosuppressive agents and severe sepsis, were the most frequent precipitants. The study demonstrates that while differentiating between HUS and TTP is sometimes difficult, in most cases the two syndromes have quite different predisposing factors and clinical parameters, enabling clinical and epidemiological profiling for these disorders.

Corresponding author
*Author for correspondence: Dr K. G. J. Pollock, Health Protection Scotland, Clifton House, Clifton Place, Glasgow, UK. (Email:
Linked references
Hide All

This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.

1. DM Williams , Acute kidney failure: a pediatric experience over 20 years. Archives of Pediatric & Adolescent Medicine 2002; 156: 893900.

2. RL Siegler , Long-term outcome and prognostic indicators in the haemolytic-uraemic syndrome. Journal of Pediatrics 1991; 118: 195200.

3. AX Garg , Long-term renal prognosis of diarrhea-associated hemolytic uremic syndrome: a systematic review, meta-analysis, and meta-regression. Journal of the American Medical Association 2003; 290: 13601370.

4. PI Tarr , CA Gordon , WL Chandler . Shiga toxin-producing Escherichia coli and the haemolytic uraemic syndrome. Lancet 2005; 365: 10731086.

5. RM Lynn , Childhood hemolytic uremic syndrome, United Kingdom and Ireland. Emerging Infectious Disease 2005; 11: 590596.

6. HM Tsai , EC Lian . Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura. New England Journal of Medicine 1998; 339: 1585–94.

7. M Furlan , von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. New England Journal of Medicine 1998; 339: 1578–84.

8. GG Levy , Mutations in a member of the ADAMTS gene family causing thrombotic thrombocytopenic purpura. Nature 2001; 413: 488494.

9. HM Tsai , von Willebrand factor and von Willebrand factor-cleaving metalloprotease activity in Escherichia coli O157:H7-associated hemolytic uremic syndrome. Pediatric Research 2001; 49: 653659.

10. G Remuzzi . HUS and TTP: variable expression of a single entity. Kidney International 2003; 32: 292308.

12. JS Dlott , Drug-induced thrombotic thrombocytopenic purpura/hemolytic uremic syndrome: a concise review. Therapeutic Apheresis and Dialysis 2004; 8: 102111.

14. WC Stewart , Survey of zoonoses recorded in Scotland between 1993 and 2002. Veterinary Record 2005; 157: 697702.

15. JA Ake , Relative nephroprotection during Escherichia coli O157:H7 infections: association with intravenous volume expansion. Pediatrics 2005; 115: 673680.

17. CS Wong , The risk of hemolytic uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections. New England Journal of Medicine 2000; 342: 19301936.

18. SK Vesely , ADAMTS-13 activity in thrombotic thrombocytopaenic purpura-hemolytic uremic syndrome: relation to presenting features and clinical outcomes in a prospective cohort of 142 patients. Blood 2003; 102: 6068.

19. WR Bell , Improved survival in thrombotic thrombocytopaenic purpura-hemolytic uremic syndrome. Clinical experience in 108 patients. New England Journal of Medicine 1991; 325: 398403.

20. A Zakarija , Clopidogrel-associated TTP. Stroke 2004; 35: 533538.

21. JR Brandt , Cholethiasis following Escherichia coli O157:H7-associated hemolytic uremic syndrome. Pediatric Nephrology 1998; 12: 222225.

23. MM Fitzpatrick , VS Shah , RS Trompeter . Long-term renal outcome of childhood haemolytic uraemic syndrome. British Medical Journal 1991; 303: 489492.

24. AX Garg , Risk of hypertension and reduced kidney function after acute gastro-enteritis from bacteria-contaminated drinking water. Canadian Medical Association Journal 2005; 173: 261268.

Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Epidemiology & Infection
  • ISSN: 0950-2688
  • EISSN: 1469-4409
  • URL: /core/journals/epidemiology-and-infection
Please enter your name
Please enter a valid email address
Who would you like to send this to? *